New Case Report on Terlipressin Use Published in BMJ Case Reports

A new publication involving terlipressin appeared on September 30, 2026. The article, titled "Acute variceal bleeding in a patient with phaeochromocytoma: the critical choice of vasoactive therapy," was published in BMJ Case Reports. Terlipressin remains an approved compound used in vasoactive therapy contexts. The publication is listed as a case report discussing treatment considerations in a specific clinical scenario. No outcome data or findings beyond the title and journal placement have been provided for this entry. The report is indexed under PubMed ID 42816107 and can be reviewed through the linked source. Readers interested in terlipressin's broader clinical and regulatory background can consult the compound overview for additional context.